TD Cowen analyst Charles Rhyee lowered the firm’s price target on Cigna (CI) to $333 from $387 and keeps a Buy rating on the shares. The firm updated its estimatesfollowing its Q3 results where it introduced its 2026 framework which calls for adj. EPS growth, EHS seeing a slight decline in adj. pre-tax inc. and CI HC growing at the high end of its LT target growth of 7-10%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna price target lowered to $330 from $370 at Goldman Sachs
- Cigna’s Strategic Transition and Growth Prospects Justify Buy Rating
- Cigna price target lowered to $350 from $385 at Raymond James
- Cigna price target lowered to $310 from $375 at Truist
- Cigna’s Earnings Call: Strong Performance Amid Challenges